Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DCI Indonesia Tbk (DCII) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

DCI Indonesia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

DCI Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? DCI Indonesia Tbk trades at Rp198,675 (market cap 473.71T, 1K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: DCI Indonesia Tbk is far larger — about 1524.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 1K). Which is the better fit depends on your goals.

DCIIDGNS
Market Cap
473.71T310.75B
Volume
1K963.6K
Lot
109.64K
Turnover
194.12M217.67M
Average Price
194,120225.89
Value
194.12M217.67M
Indicative Equilibrium Price
199,000226
Indicative Equilibrium Volume
11K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DCII
View details
DGNS
View details

About DCI Indonesia Tbk

PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.

Read more on DCII

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS